Assetmark, Inc Ptc Therapeutics, Inc. Transaction History

Assetmark, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$37.95 - $49.37 $1,593 - $2,073	-42 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$46.8 - $68.92 $93 - $137	2 Added 5.0%	42 $2,000
Q3 2020 Nov 13, 2020	SELL	$45.41 - $57.07 $363 - $456	-8 Reduced 16.67%	40 $2,000
Q2 2020 Aug 11, 2020	BUY	$42.56 - $54.98 $680 - $879	16 Added 50.0%	48 $2,000
Q1 2020 May 12, 2020	BUY	$32.37 - $59.36 $1,035 - $1,899	32 New	32 $1,000

232

78.1M

144K

54.8K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.54B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

Stay updated on Assetmark, Inc with notifications on news.